General Assembly Raised Bill No. 5620
February Session, 2016 LCO No. 2784
*02784_______INS*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)
General Assembly
Raised Bill No. 5620
February Session, 2016
LCO No. 2784
*02784_______INS*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)
AN ACT CONCERNING INSURANCE COVERAGE FOR OPIOID ANALGESICS AND REQUIRING A STUDY OF IMPEDIMENTS TO INSURANCE COVERAGE FOR SUBSTANCE USE DISORDER TREATMENTS.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (NEW) (Effective January 1, 2017) No insurance company, health care center, hospital service corporation, medical service corporation, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state an individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11), (12) and (16) of section 38a-469 of the general statutes and that provides coverage for prescription drugs shall provide coverage for more than a thirty-day supply of any opioid analgesic per initial prescription or per refill of such prescription.
Sec. 2. (NEW) (Effective January 1, 2017) No insurance company, health care center, hospital service corporation, medical service corporation, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state a group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11), (12) and (16) of section 38a-469 of the general statutes and that provides coverage for prescription drugs shall provide coverage for more than a thirty-day supply of any opioid analgesic per initial prescription or per refill of such prescription.
Sec. 3. (Effective from passage) The Insurance Commissioner shall study the impediments that exist, if any, for insureds to receive treatments for substance use disorders under their health insurance policies or health benefit plans. Such study shall include, but need not be limited to, (1) the extent to which coverage is provided under health insurance policies or health benefit plans, (2) the types of treatments covered under such policies or plans, (3) the requirements, if any, that insureds must meet for such treatments to be covered under such policies or plans, and (4) the cost-sharing requirements for insureds for such treatments. Not later than January 31, 2017, the commissioner shall submit a report, in accordance with the provisions of section 11-4a of the general statutes, to the joint standing committees of the General Assembly having cognizance of matters relating to insurance and public health, summarizing the commissioner's findings.
This act shall take effect as follows and shall amend the following sections:
Section 1 January 1, 2017 New section
Sec. 2 January 1, 2017 New section
Sec. 3 from passage New section
This act shall take effect as follows and shall amend the following sections:
Section 1
January 1, 2017
New section
Sec. 2
January 1, 2017
New section
Sec. 3
from passage
New section
Statement of Purpose:
To prohibit health insurers and other entities from providing coverage for opioid analgesics for more than a thirty-day supply per prescription or refill, and require the Insurance Commissioner to study impediments for insureds to receive substance use disorder treatment and submit a report to the joint standing committees of the General Assembly having cognizance of matters related to insurance and public health.
[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]